UCB announces Nayzilam (midazolam) nasal spray now approved by FDA to treat intermittent, stereotypic episodes of frequent seizure activity in people living with epilepsy in the US

19 May 2019 - Nayzilam allows for administration by a non-healthcare professional in patients actively seizing when and where a seizure ...

Read more →

FDA's strengthened global inspection program helps ensure generic drug safety

17 May 2019 - Consumers must have confidence in the safety and quality of generic medicines.  ...

Read more →

Athersys announces fast track designation from FDA for MultiStem program for acute respiratory distress syndrome

14 May 2019 - Athersys announced today that its clinical program evaluating MultiStem cell therapy for the treatment of acute respiratory ...

Read more →

Agile Therapeutics resubmits new drug application for its transdermal low-dose contraceptive patch, Twirla

17 May 2019 - Agile Therapeutics today announced it has resubmitted to the U.S. FDA the new drug application for its ...

Read more →

U.S. FDA approves Gattex (teduglutide) for children 1 year of age and older with short bowel syndrome

17 May 2019 - Gattex is the only glucagon-like peptide-2 analogue approved that improves intestinal absorption in patients with SBS who ...

Read more →

Celgene receives European Commission approvals for Revlimid (lenalidomide) and Imnovid (pomalidomide)-based triplet combination regimens for patients with multiple myeloma

16 May 2019 - The European Commission has approved two of Celgene’s IMiD based combination regimens. ...

Read more →

Health Canada approves injectable hydromorphone to treat opioid addiction

16 May 2019 - Canada is first country to approve the pain drug for severe opioid use disorder, says Health ...

Read more →

Instalment payments could be used across gene therapy space, Spark CEO says

16 May 2019 - In a fireside chat at the recently concluded Veeva Summit in Philadelphia, Jeff Marrazzo said payment over ...

Read more →

FDA approves first anticoagulant (blood thinner) for paediatric patients to treat potentially life-threatening blood clots

16 May 2019 - The U.S. FDA today approved Fragmin (dalteparin sodium) injection, for subcutaneous use, to reduce the recurrence of ...

Read more →

Will drugs companies follow EU agency from London to Amsterdam?

16 May 2019 - Amid the bustling skyscrapers of London’s Canary Wharf, one building stands silent and shuttered — a ...

Read more →

Sigma Healthcare leadership says it has received no worker reports of medicine mishandling

16 May 2019 - Sigma Healthcare's chief executive Mark Hooper has told investors that the company takes its obligations to ...

Read more →

Hospital drug making venture picks antibiotics as first products

15 May 2019 - Nonprofit Civica Rx plans to begin distributing vancomycin hydrochloride and daptomycin before the end of September. ...

Read more →

Drug prices in TV ads: how transparent are they?

15 May 2019 - A website launched by pharmaceutical giant Eli Lilly earlier this year leads with a daunting statement ...

Read more →

Sigma Healthcare to face investor questions over claims it mishandled prescription drugs

15 May 2019 - Pharmaceutical supplier Sigma Healthcare will face shareholder questions over claims that it failed to properly handle ...

Read more →

AbbVie announces US FDA approval of Venclexta (venetoclax) as a chemotherapy-free combination regimen for previously untreated chronic lymphocytic leukaemia patients

15 May 2019 - FDA reviewed the submission under the real-time oncology review pilot program. ...

Read more →